先进的纳米系统和新兴疗法:结核病治疗和药物耐药性的创新
Akhil Sharma1, Vikas Sharma1, Shivika Sharma1
1School of Bioengineering and Biosciences, Lovely Professional University, Jalandhar 144411, Punjab, India.
Pharmaceutics
|November 27, 2025
概括
新的纳米技术,基因编辑和免疫治疗方法提供了改进的结核病 (TB) 治疗方法. 这些先进的策略承诺更有效,个性化,少有毒的选择,以打击耐药的结核菌.
科学领域:
- 生物医学工程 生物医学工程
- 传染性疾病 传染性疾病
- 纳米医学是一种纳米医学.
背景情况:
- 结核病 (TB) 由于治疗局限性和结核菌 (Mycobacterium tuberculosis) 药物耐药性增加而构成全球卫生挑战.
- 传统疗法面临着有效性,毒性和患者服药性方面的挑战.
研究的目的:
- 审查和巩固基于纳米技术的疗法,可吸入配方,CRISPR-Cas基因编辑,宿主导疗法 (HDT) 和用于结核病管理的基于纳米粒子的疫苗的最新进展.
- 突出这些新模式的潜力,以克服现有的治疗挑战和打击耐药性.
主要方法:
- 对纳米技术应用 (脂质体,SLN,树状体,NP) 关于结核病药物输送的当前文献的综述.
- 分析CRISPR-Cas技术用于结核病的基因向和诊断.
- 对免疫调节的宿主导疗法 (如维生素D,甲胺) 的评估.
- 基于纳米粒子的疫苗平台 (mRNA,抗原结合) 的评估,以提高免疫力.
主要成果:
- 纳米载体增强药物的生物可用性,使持续释放成为可能,并向受感染的巨细胞,减少毒性和剂量频率.
- 吸入式纳米药物将药物直接输送到肺部,增加感染部位的度.
- 克里斯普尔-卡斯技术显示出对禁用耐药基因和改善诊断的承诺.
- HDT调节宿主免疫力,以增强病原体的清除.
- 纳米粒子疫苗旨在通过增强抗原呈现和引起强大的免疫力来改善BCG.
结论:
- 结合纳米医学,基因编辑和免疫调节的综合方法代表了转向个性化,有效和更安全的结核病疗法的范式转变.
- 这些创新策略具有打击耐药结核病和改善患者治疗结果的巨大潜力.
- 需要解决与监管批准,安全性,可扩展性和可访问性相关的挑战,以便广泛采用临床.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Microorganisms in Medicine and Therapeutics
920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis I
811
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis III
901
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
901


